Edgewise Therapeutics Inc (EWTX)
US$ 14.890.47%
Price Chart
Key Statistics
Market Cap
$ 1.38B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
860.97K
52W High
$ 38.12
52W Low
$ 10.60
Dividend Yield
0.00%
Beta
0.29
Technicals
50-Day MA
14.7225
200-Day MA
24.1397
52 Week High
38.12
52 Week Low
10.6
About EWTX
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.
Employees
117
Headquarters
Boulder, CO
CEO
Dr. Kevin Koch Ph.D.
Latest News
Edgewise Therapeutics (EWTX) Faces FDA Hurdle with CANYON Data | - GuruFocus
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg